Pilot Study to Evaluate the Long-term Chronic Care of Patients Who Could or do Utilize an Osseointegrated Device (OID)

UnknownOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

January 29, 2021

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions
Hearing Loss, ConductiveHearing Loss, MixedDeafness, Unilateral
Interventions
OTHER

No intervention

This is an observational study of participants that either choose or not choose to utilize an OID. This is not an intervention prescribed study, however, participants may choose uptake of standard of care intervention and obtain and utilize an OID. An OID is an FDA-approved device commonly recommended to patients with conductive, mixed, or singled-sided hearing loss. There is no experimental intervention evaluated in this study.

Trial Locations (1)

33613

RECRUITING

Department of USF Health Otolaryngology; Auditory Rehabilitation & Clinical Trials Lab, Tampa

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Oticon Medical

INDUSTRY

lead

University of South Florida

OTHER

NCT04899037 - Pilot Study to Evaluate the Long-term Chronic Care of Patients Who Could or do Utilize an Osseointegrated Device (OID) | Biotech Hunter | Biotech Hunter